Takeda Pharmaceutical (TAK) Assets (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Assets of $98.3 billion for Q2 2026, up 1.53% year-over-year from $96.8 billion in Q2 2025, and down 0.65% quarter-over-quarter from $98.9 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Assets (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Assets history runs 9 years deep, the most recent figure standing at $98.3 billion for Q2 2026.
- In Q2 2026, Assets rose 1.53% year-over-year to $98.3 billion; the TTM figure through Jun 2026 stood at $98.3 billion (up 1.53% YoY), while the FY2026 annual figure was $103.0 billion, up 10.16% from the prior year.
- Assets for Q2 2026 stood at $98.3 billion, down from $98.9 billion in the prior quarter.
- The five-year high for Assets was $113.4 billion in Q1 2022, with the low at $93.4 billion in Q1 2025.
- The 5-year median for Assets is $99.7 billion (2024), against an average of $101.4 billion.
- The sharpest annual moves came in 2022 and 2026: Assets dropped 14.43% in 2022, then climbed 5.91% in 2026.
- Takeda Pharmaceutical's Assets stood at $95.6 billion in 2022, then rose by 0.66% to $96.2 billion in 2023, then climbed by 3.27% to $99.4 billion in 2024, then climbed by 0.76% to $100.1 billion in 2025, then dropped by 1.85% to $98.3 billion in 2026.
- Business Quant data shows TAK's Assets at $98.3 billion in Q2 2026, $98.9 billion in Q1 2026, and $100.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 6.18 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 4.39 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 98.27 Bn |
| Mar 31, 2026 | 98.91 Bn |
| Dec 31, 2025 | 100.12 Bn |
| Sep 30, 2025 | 98.21 Bn |
| Jun 30, 2025 | 96.79 Bn |
| Mar 31, 2025 | 93.39 Bn |
| Dec 31, 2024 | 99.37 Bn |
| Sep 30, 2024 | 97.70 Bn |
| Jun 30, 2024 | 104.25 Bn |
| Mar 31, 2024 | 101.95 Bn |
| Dec 31, 2023 | 96.22 Bn |
| Sep 30, 2023 | 102.98 Bn |
| Jun 30, 2023 | 107.94 Bn |
| Mar 31, 2023 | 105.52 Bn |
| Dec 31, 2022 | 95.59 Bn |
| Sep 30, 2022 | 105.63 Bn |
| Jun 30, 2022 | 108.76 Bn |
| Mar 31, 2022 | 113.39 Bn |
| Dec 31, 2021 | 111.71 Bn |
| Sep 30, 2021 | 114.10 Bn |